Oxford Study Seeks to Unlock How Antidepressants Affect Young Minds
A groundbreaking study led by Oxford University is taking a closer look at how antidepressants, particularly the SSRI Fluoxetine (Prozac), work in young people. With record numbers of 15- to 29-year-olds prescribed these medications, researchers hope to uncover why the same treatment helps some but not others.
Understanding the Problem
Depression is increasingly common among young adults. Data from the UK’s Office for National Statistics (ONS) in 2022 showed that 28% of 16- to 29-year-olds experienced symptoms of depression—the highest rate among all age groups. NHS data reveals a steady rise in prescriptions: from 1.4 million in 2016 to 1.8 million in 2023 for people aged 15-29.
Despite their widespread use, antidepressants remain controversial. Many benefit from them, but others find limited relief—and some hesitate to begin treatment due to stigma or fear.
The Study: Digging Deeper into Prozac’s Effects
Oxford University’s new project focuses on Fluoxetine, a selective serotonin reuptake inhibitor (SSRI) often prescribed for depression. Led by Professor Catherine Harmer, the research team aims to determine how the drug specifically influences young brains and emotions.
“We can’t assume that the effects in adolescents are exactly the same as in adults,”
says Prof Harmer.
“Adolescence is a crucial developmental stage where depression often emerges for the first time.”
About 80 young participants are involved, and results are expected within a year. The goal: to predict who benefits most from antidepressants—and tailor treatments accordingly.
Voices from the Study: Alex and Katie’s Perspective
Two of the study’s contributors, Alex (24) and Katie (23), both have firsthand experience with depression.
Alex describes it as “a buzzing in my head that meant I couldn’t concentrate on normal things.”
Katie adds, “It just sucks the joy out of life.”
Both say antidepressants made a difference—helping neutralize mood swings and reduce constant negative thinking. Still, Katie admits she was hesitant at first:
“There’s this narrative that antidepressants are a last resort—and that can be really harmful because people wait until they’ve hit rock bottom to try them.”
Alex agrees that awareness is improving among young people but notes that “clinically, there’s still a real lag in understanding how we use antidepressants and what they actually do.”
Breaking the Stigma Around Treatment
Prof Harmer points out that antidepressants often face more judgment than other medical treatments.
“You could take hormonal medication for period pain or migraine treatment without the same criticism,” she explains.
By studying the drug’s effects in younger populations, researchers hope to make antidepressant use less stigmatized and more scientifically guided.
Prof Miranda Wolpert from the Wellcome Trust, which funds the study, emphasizes the need for evidence:
“SSRIs are vital for many young people, yet we still know too little about how they work—and why sometimes they don’t.”
Modernizing Mental Health Research
Alex and Katie have helped modernize testing tools used in earlier antidepressant research.
“A lot of the tests were from the 1970s to 1990s—outdated language, old formats,” Alex says.
Their updates aim to make participation more engaging and accessible for young adults, ensuring that future studies reflect modern experiences with mental health.
Katie hopes their work will ultimately lead to better care:
“If something good can come out of what’s been really difficult for me, and others get help from it—that’s what matters.”
Read the full aritcle here.
